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SOD1Superoxide dismutase 1 (SOD1) is an antioxidant enzyme that converts superoxide anion radicals
into hydrogen peroxide and molecular oxygen. The senescence marker protein-30 (SMP30) is a
gluconolactonase that functions as an antioxidant protein in mammals due to its involvement in
ascorbic acid (AA) biosynthesis. SMP30 also participates in Ca2+ efﬂux by activating the calmodu-
lin-dependent Ca2+-pump. To reveal the role of oxidative stress in lipid metabolism defects occur-
ring in non-alcoholic fatty liver disease pathogenesis, we generated SMP30/SOD1-double
knockout (SMP30/SOD1-DKO) mice and investigated their survival curves, plasma and hepatic lipid
proﬁles, amounts of hepatic oxidative stress, and hepatic protein levels expressed by genes related
to lipid metabolism. While SMP30/SOD1-DKO pups had no growth retardation by 14 days of age, they
did have low plasma and hepatic AA levels. Thereafter, 39% and 53% of male and female pups died by
15–24 and 89 days of age, respectively. Compared to wild type, SMP30-KO and SOD1-KO mice, by
14 days SMP30/SOD1-DKOmice exhibited: (1) higher plasma levels of triglyceride and aspartate ami-
notransferase; (2) severe accumulation of hepatic triglyceride and total cholesterol; (3) higher levels
of superoxide anion radicals and thiobarbituric acid reactive substances in livers; and (4) decreased
mRNA and protein levels of Apolipoprotein B (ApoB) in livers – ApoB is an essential component of
VLDL secretion. These results suggest that high levels of oxidative stress due to concomitant
deﬁciency of SMP30 and/or AA, and SOD1 cause abnormal plasma lipid metabolism, hepatic lipid
accumulation and premature death resulting from impaired VLDL secretion.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum
of liver disease ranging from steatosis to non-alcoholic steatohep-
atitis (NASH), and cirrhosis [1]. In NASH, intralobular inﬂammationand hepatocellular ballooning are present in addition to steatosis,
and are often accompanied by progressive ﬁbrosis. Several popula-
tion studies showed that NAFLD is closely associated with obesity,
insulin resistance and metabolic syndrome, diabetes, and dyslipi-
demia. However, the pathogenesis of NAFLD/NASH has not been
completely elucidated. One popular hypothesis is the ‘‘two-hit the-
ory’’ wherein the ‘‘ﬁrst hit’’ is insulin resistance that causes hepatic
fat accumulation and the ‘‘second hit’’ induces hepatocyte injury
and inﬂammation [2]. Although the mechanisms that cause hepa-
tocyte injury in fatty liver are not fully understood, oxidative stress
is a commonly proposed mechanism for hepatocellular injury.
Many antioxidant enzymes and molecules protect mammalian
cells from oxidative stress caused by reactive oxygen species such
as superoxide anion radicals, hydrogen peroxide, hydroxyl radicals,
and singlet oxygen, as well as reactive nitrogen species such as per-
oxynitrite [3]. Superoxide dismutase (SOD) is an antioxidant
enzyme that converts superoxide anion radicals into hydrogen
Y. Kondo et al. / FEBS Open Bio 4 (2014) 522–532 523peroxide and molecular oxygen. SOD consists of three isozymes:
copper/zinc SOD (Cu, Zn-SOD, SOD1) that localizes in the cytosol,
nucleus, and mitochondrial intermembrane space, manganese
SOD (Mn-SOD, SOD2), which is localized in the mitochondrial
matrix, and extracellular Cu, Zn-SOD (EC-SOD, SOD3). In a previous
study we reported that SOD1-knockout (KO) mice showed age-
related macular degeneration [4], retinal degeneration [5], skin
atrophy [6], osteoporosis [7], deterioration of Alzheimer’s disease
[8], and luteal [9] and lacrimal degeneration [10]. Other groups
showed SOD1-KO phenotypes that included age-related cataracts
[11], hepatocellular carcinoma [12], muscle atrophy [13], and
hemolytic anemia [14].
The liver plays a key role in lipid metabolism including uptake
and de novo synthesis of free fatty acids (FFA) followed by conver-
sion of FFA into triglycerides (TG) by esteriﬁcation [15]. TG are
secreted into the circulation as Apolipoprotein B (ApoB)-containing
very low-density lipoprotein (VLDL) or stored in hepatocytes as TG
vacuoles. FFA that is not esteriﬁed into TG is metabolized by b-oxi-
dation in the liver. VLDL transports not only endogenously synthe-
sized lipids, in particular TG, but also some cholesterol and
cholesteryl esters to peripheral tissues. ApoB100 is absolutely
required for VLDL assembly and secretion. The quality of VLDL is
strictly controlled in multiple steps from production to secretion
by ApoB100 degradation [16]. Regarding lipid metabolism in the
liver, we showed that SOD1-KO mice exhibited increased lipid per-
oxidation and hepatic TG accumulation due to decreases in VLDL
secretion from the liver caused by oxidative degradation of ApoB.
This result suggests that superoxide anion radicals may be
involved in abnormal lipid metabolism in the mouse liver [17].
We originally identiﬁed the 34 kDa senescence marker protein-
30 (SMP30) in rat liver and also showed that SMP30 levels decrease
with age [18,19]. SMP30 participates in Ca2+ efﬂux by promoting
calmodulin-dependent Ca2+ pump activity in HepG2 cells, which
confers resistance to cell injury caused by high intracellular Ca2+
concentrations [20]. We reported that SMP30-KO mice livers are
highly susceptible to tumor necrosis factor-a- and Fas-induced
apoptosis, suggesting that SMP30 has a protective role in cell injury
[21]. Furthermore, SMP30-KO mice hepatocytes exhibited
increased hepatic TG accumulation, total cholesterol (T-cho), and
phospholipid (PL), as well as abnormally enlarged mitochondria
[22]. Previously, we identiﬁed SMP30 as a gluconolactonase that
catalyzes lactonization of L-gulonic acid in the penultimate step
of mammalian L-ascorbic acid (AA) biosynthesis [23,24]. AA is a
free radical scavenger that acts as an electron donor and cofactor
in reactions catalyzed by dopamine-b-hydroxylase and collagen
prolyl- and lysyl- hydroxylase [25,26]. In guinea pigs and primates
including humans, the capacity to synthesize AA has been lost due
to many mutations in the L-gulono-c-lactone oxidase gene,
whereas most vertebrates can synthesize AA in vivo. We reported
that AA-depleted SMP30-KO mice showed ultraviolet radiation
type B-induced cataracts [27], skin atrophy [28], impaired cate-
cholamine synthesis [29], age-related hearing loss [30], increased
superoxide anion radical generation in the brain [31], pulmonary
emphysema [32], and abnormal insulin release from pancreatic
islets [33]. We also reported that SMP30 deﬁciency independent
of AA worsens glucose tolerance by impairing acute insulin secre-
tion [34], causes coronary artery spasms that are triggered by
chronic thiol oxidation [35], impairs myocardium-induced dilation
of coronary arterioles [36] and affects astrocyte activation, which
exacerbates Parkinson’s pathology [37]. In addition, SMP30-KO
mice on a Leprdb/db background exhibit increases in small dense-
LDL and severe fatty liver accompanied by numerous inﬂammatory
cells and increased oxidative stress, suggesting that SMP30 is clo-
sely associated with NAFLD pathogenesis [38].
To address the pathological role of reactive oxygen species in
lipid metabolism involved in NAFLD/NASH pathogenesis, wegenerated SMP30/SOD1-double knockout (SMP30/SOD1-DKO)
mice, and investigated oxidative stress and lipid metabolism in
the livers of these mice. In this study, we show that SMP30/
SOD1-DKO mice died after 15 days without obvious growth retar-
dation, and at 14 days of age exhibited low AA levels, high levels of
plasma TG and aspartate aminotransferase (AST), and lipid accu-
mulation in response to impaired VLDL secretion, which is caused
by decreased ApoB gene expression and ApoB protein degradation
that occurs in the presence of high levels of superoxide anion rad-
icals and/or lipid peroxide.
2. Results
2.1. Smp30Y/Sod1/ male and Smp30/Sod1/ female mice died
after day 15 of the neonatal period
Smp30Y/Sod1/ male and Smp30/Sod1/ female mice were
born healthy with expected Mendelian frequencies. Out of 243
pups examined in the mating pair of Smp30Y/Sod1+/ male and
Smp30/Sod1+/ female mice, there were 70 (28.8%) Smp30Y/
Sod1+/+ and Smp30/Sod1+/+, 116 (47.7%) Smp30Y/Sod1+/ and
Smp30/Sod1+/, 57 (23.5%) Smp30Y/Sod1/ mice and Smp30/
Sod1/ mice. For the control mice, out of 102 pups examined in
the mating pair of Smp30Y/+Sod1+/ male and Smp30+/+Sod1+/
female mice, there were 24 (23.5%) Smp30Y/+Sod1+/+ and Smp30+/
+Sod1+/+, 55 (53.9%) Smp30Y/+Sod1+/ and Smp30+/+Sod1+/, 23
(22.5%) Smp30Y/+Sod1/ and Smp30+/+Sod1/ mice. From survival
analysis of the male mice, Smp30Y/Sod1/ mice died starting at
15 days of age, and eventually 39% of the mice died by 24 days of
age, although mice in the other ﬁve experimental groups survived
(p < 0.05 versus Smp30Y/+Sod1+/+, Smp30Y/+Sod1+/, and Smp30Y/+
Sod1/, p < 0.01 versus Smp30Y/Sod1+/ using a log-rank test)
(Fig. 1A). Similarly, Smp30/Sod1/ female mice began to die at
15 days of age, and 53% of these mice eventually died up until
89 days of age, although the other ﬁve experimental groups had
hardly any deaths (p < 0.001 versus Smp30+/+Sod1+/+, Smp30+/
+Sod1+/, and Smp30+/+Sod1/, p < 0.05 versus Smp30/Sod1+/+
and Smp30/Sod1+/ by using log-rank test). At 14 days of age,
the appearance and size of the Smp30Y/Sod1/ male and
Smp30/Sod1/ female mice were similar to the other ﬁve exper-
imental groups (Fig. 1B). Smp30Y/Sod1/ male mice gained
weight and the body weight change was not signiﬁcantly different
from the other ﬁve experimental groups at 14 days of age (Fig. 1C).
While the body weight of Smp30/Sod1/ female mice also
increased, the body weight changes were signiﬁcantly (16%) lower
than that of Smp30+/+Sod1+/ animals at 14 days of age (p < 0.05).
We next determined the AA and DHA levels in the plasma and
livers of Smp30Y/Sod1/ male and Smp30/Sod1/ female mice
at 14 days of age. The AA plus DHA levels in plasma from
Smp30Y/Sod1+/+, Smp30Y/Sod1+/, and Smp30Y/Sod1/ male mice
were 7.3%, 6.7%, and 7.5% that of Smp30Y/+Sod1+/+ mice (62.9 lM),
respectively (Fig. 1D). In plasma from Smp30/Sod1+/+, Smp30/-
Sod1+/, and Smp30/Sod1/ female mice, the AA plus DHA levels
were 7.0%, 6.8%, and 7.6% that of Smp30+/+Sod1+/+ mice (63.5 lM),
respectively. The AA plus DHA levels in Smp30Y/+Sod1/ male
and Smp30+/+Sod1/ female mice were signiﬁcantly (25% and
18%, respectively) lower compared with Smp30Y/+Sod1+/+ male
and Smp30+/+Sod1+/+ female mice (p < 0.001 and p < 0.05). As shown
in Fig. 1E, the AA plus DHA levels of livers from Smp30Y/Sod1+/+,
Smp30Y/Sod1+/, and Smp30Y/Sod1/ male mice were 13.9%,
13.6%, and 13.9% that of Smp30Y/+Sod1+/+ mice (1.32 lmol/g tissue),
respectively. In livers from Smp30/Sod1+/+, Smp30/Sod1+/, and
Smp30/Sod1/ female mice, the AA plus DHA levels of plasma
were 14.8%, 14.3%, and 15.7% of Smp30+/+Sod1+/+ mice (1.08 lmol/
g tissue), respectively. The DHA per AA plus DHA in the plasma
and livers of the six experimental groups were respectively
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Fig. 1. Establishment of Smp30Y/Sod1/ male mice and Smp30/Sod1/ female mice. (A) Cumulative survival rate in each experimental group of mice. (B) Appearance of
Smp30Y/Sod1/ male mice and Smp30/Sod1/ female mice at 14 days of age. (C) Body weight change in each experimental group (n = 10–11) between 7 and 14 days of
age. The body weight of mice at 7 days was set at 100%. Open circles, Smp30Y/+Sod1+/+ or Smp30+/+Sod1+/+ mice; open triangles, Smp30Y/+Sod1+/ or Smp30+/+Sod1+/ mice; open
squares, Smp30Y/+Sod1/ or Smp30+/+Sod1/ mice; ﬁlled circles, Smp30Y/Sod1+/+ or Smp30/Sod1+/+ mice; ﬁlled triangles, Smp30Y/Sod1+/ or Smp30/Sod1+/ mice; ﬁlled
squares, Smp30Y/Sod1/ or Smp30/Sod1/ mice. Values are given as means ± SEM. (D and E) Ascorbic acid (AA; ﬁlled columns) and dehydroascorbic acid (DHA; gray
columns) concentration in plasma (D) and livers (E) from each experimental group of mice (n = 7–11) at 14 days. Values are given as means ± SEM (AA plus DHA).
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females.
2.2. Smp30Y/Sod1/ male mice show hypertriglyceridemia and liver
injury
The blood biochemical parameters of 14 day old animals in the
six experimental groups are presented in Table 1. Plasma TGconcentrations were signiﬁcantly higher in Smp30Y/Sod1/ male
mice (84.0 ± 10.0 mg/dL) than in Smp30Y/+Sod1+/+ (35.8 ± 5.4 mg/
dL, p < 0.001), Smp30Y/+Sod1+/ (33.2±8.9 mg/dL, p < 0.001),
Smp30Y/+Sod1/ (43.0 ± 5.9 mg/dL, p < 0.01), Smp30Y/Sod1+/+
(41.5 ± 2.7 mg/dL, p < 0.01), and Smp30Y/Sod1+/ mice
(34.0 ± 7.0 mg/dL, p < 0.001). There were no signiﬁcant differences
in plasma T-cho and FFA levels among the six experimental groups.
Plasma AST concentrations in Smp30Y/Sod1/ male mice
Table 1
Biochemical parameters of blood plasma in six experimetal groups of male mice.
Smp30Y/+Sod1+/+ Smp30Y/+Sod1+/ Smp30Y/+Sod1/ Smp30Y/Sod1+/+ Smp30Y/Sod1+/ Smp30Y/Sod1/
Triglyceride (mg/dL) 35.8 ± 5.4 33.2 ± 8.9 43.0 ± 5.9 41.5 ± 2.7 34.0 ± 7.0 84.0 ± 10.0,§,–,,§§
Cholesterol (mg/dL) 104.5 ± 5.7 122.2 ± 8.0 124.7 ± 11.5 119.7 ± 3.4 119.9 ± 4.1 116.4 ± 10.8
Free fatty acid (mEq/L) 0.51 ± 0.13 0.75 ± 0.31 0.92 ± 0.21 0.80 ± 0.04 0.69 ± 0.08 0.84 ± 0.15
Aspartate aminotransferase (IU/L) 61.7 ± 4.6 58.6 ± 0.9 66.3 ± 4.2 55.2 ± 3.0 64.6 ± 11.2 135.9 ± 13.8,§,||,,§§
Alanine aminotransferase (IU/L) 19.5 ± 0.9 21.8 ± 1.0 19.0 ± 0.5 16.4 ± 0.4 19.0 ± 1.9 22.3 ± 0.7⁄⁄
Glucose (mg/dL) 163.6 ± 10.2 153.6 ± 8.1 181.0 ± 16.7 164.1 ± 9.0 147.5 ± 5.2 115.0 ± 7.0⁄,||,⁄⁄
Insulin (ng/mL) 0.15 ± 0.07 0.34 ± 0.11 0.06 ± 0.04 0.34 ± 0.02 0.16 ± 0.05 0.15 ± 0.05
⁄p < 0.05 and p < 0.001 versus Smp30Y/+Sod1+/+, p < 0.01 and §p < 0.001 versus Smp30Y/+Sod1+/, –p < 0.01 and ||p < 0.001 versus Smp30Y/+Sod1/, ⁄⁄p < 0.05, p < 0.01, and
p < 0.001 versus Smp30Y/Sod1+/+, §§p < 0.001 versus Smp30Y/Sod1+/. Values are given as means ± SEM of animals (n = 5–10).
Y. Kondo et al. / FEBS Open Bio 4 (2014) 522–532 525(135.9 ± 13.8 IU/L) were signiﬁcantly higher than those of Smp30Y/+
Sod1+/+ (61.7 ± 4.6 IU/L, p < 0.001), Smp30Y/+Sod1+/ (58.6 ± 0.9 IU/L,
p < 0.001), Smp30Y/+Sod1/ (66.3 ± 4.2 IU/L, p < 0.001), Smp30Y/-
Sod1+/+ (55.2 ± 3.0 IU/L, p < 0.001), and Smp30Y/Sod1+/ mice
(64.6 ± 11.2 IU/L, p < 0.001). In females, plasma AST concentrations
in Smp30/Sod1/ mice (156.7 ± 16.0 IU/L) were signiﬁcantly
higher than Smp30+/+Sod1+/+ (65.0 ± 4.1 IU/L, p < 0.001), Smp30+/
+Sod1+/ (60.0 ± 3.5 IU/L, p < 0.001), Smp30+/+Sod1/
(71.1 ± 3.1 IU/L, p < 0.001), Smp30/Sod1+/+ (74.9 ± 5.0 IU/L,
p < 0.001), and Smp30/Sod1+/ mice (76.8 ± 8.2 IU/L, p < 0.001).
The plasma alanine aminotransferase concentration was signiﬁ-
cantly higher in Smp30Y/Sod1/ male mice (22.3 ± 0.7 IU/L) com-
pared with Smp30Y/Sod1+/+ (16.4 ± 0.4 IU/L, p < 0.05) animals,
although there were no signiﬁcant differences among females inA
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the six experimental groups.
2.3. Increased hepatic lipid levels (TG and T-cho) and lipid
peroxidation (TBARS) in Smp30Y/Sod1/ male mice
As shown in Fig. 2A and B, histological examination of hepatic
tissues revealed increased steatosis in Smp30Y/Sod1/ male and
Smp30/Sod1/ female mice at 14 days of age. In contrast,Smp30 -/- Sod1-/-
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526 Y. Kondo et al. / FEBS Open Bio 4 (2014) 522–532apparent histological abnormalities were not observed for the
other ﬁve experimental groups. Hepatic TG was signiﬁcantly
higher in Smp30Y/Sod1/ male mice than those of the other ﬁve
experimental groups (p < 0.001) (Fig. 3A). Compared with
Smp30Y/+Sod1+/+ mice, hepatic TG was signiﬁcantly higher in
Smp30Y/+Sod1/ mice (p < 0.05). Hepatic TC in Smp30Y/Sod1/
mice was signiﬁcantly higher than that of Smp30Y/+Sod1+/+ animals
(p < 0.05) (Fig. 3B). There were no signiﬁcant differences in hepatic
PL and FFA levels among the six experimental groups (Fig. 3C and
D).
To examine oxidative stress in livers from Smp30Y/Sod1/
mice, a TBARS assay was performed. Hepatic TBARS were signiﬁ-
cantly higher in Smp30Y/+Sod1/ mice compared to those of
Smp30Y/Sod1+/+ (p < 0.01) and Smp30Y/Sod1+/ mice (p < 0.05)
(Fig. 3E). Hepatic TBARS in Smp30Y/Sod1/ mice were signiﬁ-
cantly higher than those of Smp30Y/+Sod1+/+ (p < 0.001), Smp30Y/
+Sod1+/ (p < 0.01), Smp30Y/Sod1+/+ (p < 0.001), and Smp30Y/-
Sod1
+/
mice (p < 0.001). Compared with Smp30Y/+Sod1/, hepatic
TBARS were higher in Smp30Y/Sod1/ mice, although the differ-
ences did not reach statistical signiﬁcance (p = 0.12).
2.4. Increased superoxide anion radical in liver sections from Smp30Y/
Sod1/ male mice
To evaluate superoxide anion radicals in livers from Smp30Y/-
Sod1
/
mice, DHE staining was conducted using frozen liver sec-
tions. DHE is oxidized upon reaction with superoxide anion
radical to form ethidium bromide, which intercalates in nuclear
DNA. DHE ﬂuorescence was increased in liver sections from
Smp30Y/+Sod1/ mice relative to those of Smp30Y/+Sod1+/+,
Smp30Y/+Sod1+/, Smp30Y/Sod1+/+, and Smp30Y/Sod1+/ miceD
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Fig. 3. Increased triglyceride, cholesterol, and thiobarbituric acid reactive substances (T
Phospholipid, (D) Free fatty acid, and (E) TBARS in livers from each experimental group(Fig. 4). Furthermore, the DHE ﬂuorescence in Smp30Y/Sod1/
mice was markedly increased compared with the other ﬁve exper-
imental groups.
2.5. Decreased ApoB protein levels in livers from Smp30Y/Sod1/
male mice
To reveal a mechanism for hepatic steatosis in Smp30Y/Sod1/
male mice, we examined liver ApoB protein and mRNA expression
levels. Protein levels of ApoB100 and its spliced variant ApoB48
were decreased in liver microsome fractions from Smp30Y/+Sod1/
 mice relative to Smp30Y/+Sod1+/+, Smp30Y/+Sod1+/, Smp30Y/-
Sod1+/+, and Smp30Y/Sod1+/animals, whilst these levels were fur-
ther decreased in Smp30Y/Sod1/ mice compared with Smp30Y/+
Sod1/ mice (Fig. 5A). Apob mRNA levels were signiﬁcantly lower
in Smp30Y/Sod1/ mice than those of Smp30Y/+Sod1+/+ (p < 0.01),
Smp30Y/+Sod1+/ (p < 0.05), Smp30Y/Sod1+/+ (p < 0.001) and
Smp30Y/Sod1+/ mice (p < 0.001) (Fig. 5B). There were also no dif-
ferences among the six experimental groups in protein levels of
MTP and Grp78, both of which are known to affect ApoB protein
levels in VLDL in liver microsome fractions.
2.6. Altered transcription factor protein levels related to lipid
metabolism in livers of Smp30Y/Sod1/ male mice
Next, we investigated the hepatic protein levels of transcription
factors related to lipid metabolism in Smp30Y/Sod1/ male mice.
For lipogenesis-related genes, protein levels of the SREBP1c precur-
sor were signiﬁcantly lower in Smp30Y/Sod1/ mice than those of
Smp30Y/+Sod1+/+ (p < 0.05), Smp30Y/+Sod1+/ (p < 0.01), Smp30Y/-
Sod1+/+ (p < 0.01) and Smp30Y/Sod1+/ mice (p < 0.05) (Fig. 6A).p<0.05
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BARS) in livers of Smp30Y/Sod1/ male mice. (A) Triglyceride, (B) Cholesterol, (C)
at 14 days of age. Values are given as means ± SEM of ﬁve animals.
Smp30 Y/+Sod1-/-Smp30 Y/+Sod1+/-Smp30 Y/+Sod1+/+
Smp30 Y/- Sod1-/-Smp30 Y/- Sod1+/-Smp30 Y/- Sod1+/+
Fig. 4. Increased generation of superoxide anion radicals in livers from Smp30Y/
Sod1/ male mice. Representative images of dihydroethidium staining in liver
sections from each experimental group at 14 days of age. Scale bar is 50 lm.
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were signiﬁcantly lower relative to Smp30Y/+Sod1+/ mice
(p < 0.05). Compared with Smp30Y/+Sod1+/+ and Smp30Y/+Sod1+/
mice, protein levels of mature SREBP1c were signiﬁcantly lower
in Smp30Y/+Sod1/ (p < 0.001 and p < 0.01), Smp30Y/Sod1+/+
(p < 0.001 and p < 0.01), and Smp30Y/Sod1+/ (p < 0.01 versus
Smp30Y/+Sod1+/+) mice, as well as Smp30Y/Sod1/ mice (p < 0.001
and p < 0.01), although there was no signiﬁcant difference between
Smp30Y/+Sod1+/ and Smp30Y/Sod1+/ mice (Fig. 6B). Protein levels
of mature SREBP2 were signiﬁcantly lower in Smp30Y/Sod1+/+ ani-
mals than those of Smp30Y/+ mice (Smp30Y/+Sod1+/+, Smp30Y/+Sod1+/
, and Smp30Y/+Sod1/) (p < 0.001), and signiﬁcantly lower in
Smp30Y/Sod1+/ and Smp30Y/Sod1/ mice compared with
Smp30Y/+Sod1/ mice (p < 0.05) (Fig. 6C). The SREBP2 precursor
was not detected in liver homogenates. Protein levels of PPARa,
which is involved in fatty acid catabolism, were signiﬁcantly lower
in Smp30Y/+Sod1/ (p < 0.05), Smp30Y/Sod1+/ (p < 0.05), and
Smp30Y/Sod1/ mice (p < 0.01) compared to that of Smp30Y/
+Sod1+/+ mice (Fig. 6D).
3. Discussion
In the present study we established SMP30/SOD1-DKO mice to
assess the possible involvement of SMP30 and SOD1 in NAFLD/
NASH. SMP30/SOD1-DKO mice died at 15 days of age withoutA
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Fig. 5. Decreased Apolipoprotein B (ApoB) levels in livers of Smp30Y/Sod1/ male mic
protein (MTP), and glucose-regulated protein 78 kDa (Grp78) in liver microsome fraction
mRNA for the Apob gene was measured using quantitative real-time polymerase chain
expressed as arbitrary unit. The values from Smp30Y/+Sod1+/+ male mice were assigned aobvious growth retardation, and at 14 days of age exhibited low
plasma and hepatic levels of AA, higher plasma levels of TG and
AST, higher hepatic TG and T-cho, lower hepatic protein levels of
ApoB and PPARa, and higher superoxide anion radicals and TBARS
in the liver compared with wild-type, SMP30-KO, and SOD1-KO
mice. These results suggest that a concomitant deﬁciency of
SMP30 and SOD1 causes high levels of oxidative stress in the liver
that results in abnormal plasma lipid and hepatic lipid accumula-
tion due to impaired VLDL secretion that occurs following
decreased expression and protein degradation of ApoB. These
defects would result in premature death.
Although nursing of Smp30Y/Sod1/ male and Smp30/Sod1/
 female pups was frequently observed and these animals showed
no growth retardation by 14 days of age, 39% of Smp30Y/Sod1/
and 53% of Smp30/Sod1/ mice died by 15–24 and 89 days of
age, respectively, although the remaining mice survived more than
250 days (Fig. 1A). During mating and breeding periods, water
given to Smp30/Sod1+/ dams was supplemented with 1.5 g/L
AA. In our previous study, such supplementation was sufﬁcient
to maintain plasma and tissue AA to levels in Smp30Y/ mice that
were equivalent to Smp30Y/+ mice, even through adulthood [39].
However, plasma and hepatic AA levels in Smp30Y/ male and
female pups at 14 days of age were remarkably and unexpectedly
lower compared to Smp30Y/+ pups (Fig. 1D and E), presumably
because of low AA levels in milk from Smp30/Sod1+/ dams. Still,
low AA levels were sufﬁcient to prevent scurvy, so that Smp30Y/-
Sod1
+/+
, Smp30/Sod1+/+, Smp30Y/Sod1+/and Smp30/Sod1+/
pups grew normally (Fig. 1A–C). As such, further work will be
required to clarify the cause of premature death in Smp30Y/-
Sod1
/
and Smp30/Sod1/ mice. Interestingly, plasma AA levels
of Smp30Y/+Sod1/ and Smp30+/+Sod1/ mice were signiﬁcantly
lower than that of Smp30Y/+Sod1+/+ and Smp30+/+Sod1+/+ mice
(Fig. 1D and E). This result might suggest that increased levels of
superoxide anion radicals caused by SOD1 deﬁciency resulted in
possible oxidation and degradation of AA in the animals.
A noteworthy ﬁnding of this study is that Smp30Y/Sod1/ mice
showed increased levels of superoxide anion radicals and lipid per-
oxidation in the liver compared to Smp30Y/+Sod1/ mice in the
postnatal period (Figs. 3E and 4). Elchuri et al. previously reported
that compared to Sod1+/+ mice, higher amounts of reactive oxygen
species-mediated damage of DNA, protein, and lipids accompanied
by lower levels of glutathione peroxidase were observed in adult
Sod1/ mice [12]. We also found increased lipid peroxidation in
livers from 50 week old Sod1/ mice [17]. Furthermore, we
observed that AA-depleted Smp30Y/ mice showed higher amounts
of oxidized protein that was accompanied by alterations in/-
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Fig. 6. Decreased sterol regulatory element binding protein (SREBP)-1c, SREBP2, and peroxisome proliferator-activated receptor-a (PPARa) levels in livers from Smp30Y/
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were assigned a relative value of 1.0. Values are given as means ± SEM of three animals.
528 Y. Kondo et al. / FEBS Open Bio 4 (2014) 522–532antioxidant enzymes, higher SOD activity due to increased SOD1
protein levels, and decreased catalase protein levels [40]. In addi-
tion, Smp30Y/ mice on a Leprdb/db background exhibited severe
fatty liver with increased lipid peroxidation. In this study, cell
injury in hepatocytes was apparent in Smp30Y/Sod1/ mice as
shown by the higher AST levels. Although whether the enzymes
and small antioxidant molecules in Smp30Y/Sod1/ mice were
altered is unclear, this result suggests that SOD1 and SMP30/AA
collaboratively exert protective roles against superoxide anion rad-
icals and lipid peroxidation in vivo.
A novel ﬁnding of this study is that Smp30Y/Sod1/ mice
exhibited severe hepatic accumulation of TG and T-cho compared
with Smp30Y/+Sod1/ mice, which also showed TG accumulation
(Fig. 3A and B) that likely results from an imbalance between TG
synthesis by esteriﬁcation of FFA and VLDL secretion [15]. Since
we observed no alterations in hepatic FFA levels in any experimen-
tal group (Fig. 3D), the observed hepatic TG accumulation inSmp30Y/Sod1/ mice may have resulted from impaired VLDL
secretion in the liver. We previously reported that high levels of
oxidative stress enhanced impairment of VLDL secretion due to
ApoB degradation in the livers of adult Sod1/ mice fed normal
and high-fat diets [17]. We consistently observed in this study that
protein levels of ApoB100 and ApoB48 were lower in the livers of
Smp30Y/+Sod1/ mice relative to those from Smp30Y/+Sod1+/+ ani-
mals (Fig. 5A). Andreo et al. showed that the superoxide anion rad-
ical is required for lipid peroxidation in docosahexaenoic acid-
induced ApoB degradation, although the lipid peroxide levels
appear to be correlated with hepatic ApoB100 degradation [41].
Thus, our results suggest that enhanced hepatic ApoB degradation
in Smp30Y/Sod1/ mice may be attributed to high levels of lipid
peroxide and superoxide anion radical due to SMP30 deﬁciency
and AA insufﬁciency. In addition, we observed that Apob mRNA
levels were lower in Smp30Y/Sod1/ mice than that of Smp30Y/
+Sod1+/+ mice. Interestingly, Huynch et al. reported that mice
Y. Kondo et al. / FEBS Open Bio 4 (2014) 522–532 529lacking hepatic leptin signaling decrease hepatic Apob mRNA, and
upon re-expression of functional leptin receptors in the liver, hepa-
tic ApoB transcript levels return to wild-type levels [42]. We also
reported that Smp30Y/+ and Smp30Y/ mice lacking hepatic leptin
signaling show decreased Apob mRNA levels in the livers [38].
Although, it is uncertain whether or not hepatic leptin signaling
in fatty livers of Smp30Y/Sod1/mice is obscured, decreased ApoB
transcription levels could also account for decreased protein levels
of ApoB100 and ApoB48 in the liver.
Decreased VLDL secretion typically leads to low levels of plasma
TG. However, compared to the other experimental groups, Smp30Y/
Sod1/ mice showed higher plasma TG, but not TC and FFA
(Table 1), suggesting that uptake of TG-rich VLDL into the liver
from blood might decrease in Smp30Y/Sod1/ mice. Hepatic FFA
levels are determined by uptake, de novo synthesis, and b-oxida-
tion of FFA in livers. Despite the absence of alterations in hepatic
and plasma FFA levels among all experimental groups, major
changes in master transcription factors involved in regulating
expression of hepatic lipid metabolism genes were observed.
Protein levels of PPARa, which regulates genes involved in b-oxida-
tion of FFA, were lower in Sod1/ mice (Smp30Y/Sod1/ mice and
Smp30Y/+Sod1/ mice) compared with Smp30Y/+Sod1+/+ mice
(Fig. 6D), suggesting that superoxide anion radicals are associated
with mitochondrial and peroxisomal FFA b-oxidation. Compared
with Smp30Y/+Sod1+/+ mice, the decrease in protein levels of mature
SREBP1c that regulates genes that participate in FFA and TG syn-
thesis in Smp30Y/Sod1+/+, Smp30Y/+Sod1/, and Smp30Y/Sod1/
mice likely suppresses lipid accumulation (Fig. 6B). Protein levels
of mature SREBP2, which regulates genes involved in cholesterol
synthesis, were lower in Smp30Y/ mice (Smp30Y/Sod1/ mice
and Smp30Y/Sod1+/+ mice) relative to Smp30Y/+Sod1+/+ mice
(Fig. 6C). In our previous study Smp30Y/ mice showed hepatic
accumulation of TG, T-cho, and PL with age [22]. Taken together,
these results suggest that SMP30 deﬁciency and/or AA insufﬁ-
ciency might be relevant to cholesterol metabolism.
Further studies will be required to clarify the molecular mech-
anism involved in the alteration of lipid homeostasis and reactive
oxygen species metabolism caused by concomitant deﬁciency of
SMP30 and/or AA, and SOD1. However, our data suggest that high
levels of oxidative stress caused by defects in the antioxidant sys-
tem resulted in hepatic lipid accumulation via altered lipid metab-
olism, predominantly decreased expression and protein
degradation of ApoB, and premature death in non-obese mice,
and together support that oxidative stress might be one possible
cause of NAFLD.
4. Materials and methods
4.1. Animals and experimental protocol
Sod1/ mice were obtained from the Jackson Laboratory (Bar
Harbor, ME, USA) and backcrossed with C57BL/6NCrSlc mice (Japan
SLC, Inc., Shizuoka, Japan) for ﬁve to six generations. SMP30-KO
mice were established and maintained as described previously
[21]. The Smp30 gene is located on the X chromosome, so hetero-
zygous SMP30-KO male mice do not exist. Because SMP30 is the
penultimate enzyme in the AA biosynthetic pathway, SMP30-KO
mice cannot synthesize AA in vivo [23]. To avoid any effects of
AA deﬁciency, SMP30-KO mice were given free access to water
supplemented with 1.5 g/L AA (DSM Nutrition Japan, Tokyo, Japan)
and 10 lM ethylenediaminetetraacetic acid (EDTA) [39]. Sod1/
male mice were ﬁrst crossed with Smp30/ female mice to pro-
duce Smp30Y/Sod1+/male mice and Smp30+/Sod1+/ female mice.
Next, Smp30Y/Sod1+/male mice and Smp30+/Sod1+/ female mice
were interbred to produce Smp30Y/Sod1+/male mice and Smp30/
Sod1+/ female mice. Studies were conducted on offspring pro-duced by mating Smp30Y/Sod1+/ male mice with Smp30/-
Sod1
+/
female mice supplemented with 1.5 g/L AA and 10 lM
EDTA, to give Smp30Y/Sod1+/+, Smp30Y/Sod1+/, and Smp30Y/-
Sod1
/
male mice and Smp30/Sod1+/+, Smp30/Sod1+/, and
Smp30/Sod1/ female mice. To produce control mice, Sod1+/
mice supplemented with 10 lM EDTA water were mated to gener-
ate Smp30Y/+Sod1+/+, Smp30Y/+Sod1+/, and Smp30Y/+Sod1/ male
mice and Smp30+/+Sod1+/+, Smp30+/+Sod1+/, and Smp30+/+Sod1/
female mice. All mice were fed an autoclaved commercial chow
diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan). Mice were main-
tained on a 12-h light/dark cycle in a controlled environment. All
experimental procedures using laboratory animals were approved
by the Animal Care and Use Committee of the Tokyo Metropolitan
Institute of Gerontology (Permit Number: 12016).
4.2. Genotyping
Smp30 genotyping was performed by polymerase chain reaction
using genomic DNA isolated from the tail tip as reported previously
[21]. Sod1 genotypes were determined as described previously
with slight modiﬁcations [17]. Polymerase chain reactions to
determine both genotypes were performed under the following
conditions: 1 cycle of 94 C for 3 min; 35 cycles of 94 C for 1
min, 55 C for 1 min, and 72 C for 2 min; followed by 1 cycle of
72 C for 5 min. Mice were maintained on a 12-h light/dark cycle
in a controlled environment.
4.3. Collection of blood and liver tissue
All mice were anesthetized at the age of 14 days. Blood was
obtained from the inferior vena cava, anticoagulated with EDTA,
and subsequently centrifuged at 880g for 15 min at 4 C. Mice
were systemically perfused with ice-cold phosphate buffered sal-
ine through the hepatic portal vein to wash out any remaining
blood cells. The livers were then removed and ﬁxed with 10% neu-
tral buffered formalin or snap frozen in Tissue-Tek OCT com-
pound (Sakura Finetek Japan Co., Ltd., Tokyo, Japan) for
histological analysis, or frozen in liquid nitrogen for biochemical
analysis. Frozen samples were stored at 80 C until use.
4.4. Determination of AA and DHA levels in plasma and livers
Amounts of AA and dehydroascorbic acid (DHA), an oxidized
form of AA, were determined by high-performance liquid chroma-
tography using an Atlantis dC18 5-lm column (4.6  150 mm;
Nihon Waters K.K., Tokyo, Japan) as described previously [43].
Plasma was mixed with equal amount of 10% metaphosphoric acid
and 1 mM EDTA, and centrifuged at 21,000g for 15 min at 4 C.
Livers were homogenized in 14 vol 5.4% metaphosphoric acid and
1 mM EDTA, and the homogenate was then centrifuged at
21,000g for 15 min at 4 C. To reduce DHA to AA for determina-
tion of AA plus DHA, 90 lL of supernatant was incubated with
10 lL 350 mM Tris(2-carboxyethyl)phosphine hydrochloride for
2 h at 4 C. The mobile phase was 50 mM phosphate buffer (pH
2.8), 0.2 g/L EDTA, and 2% methanol at a ﬂow rate of 1.3 mL/min,
and electrical signals were recorded using an electrochemical
detector equipped with a glassy carbon electrode at +0.6 V. The
value of DHA was determined by subtracting AA from AA plus
DHA.
4.5. Biochemical analysis of plasma
Plasma TG, T-cho, FFA, AST, alanine aminotransferase, and glu-
cose levels were measured by enzymatic assay kits (Wako Pure
Chemicals Industries, Osaka, Japan). Plasma insulin levels were
measured using an enzyme-linked immunoassay system (Ultra
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Science Inc., Kanagawa, Japan).
4.6. Histological examination of liver
To evaluate histological changes, ﬁxed liver sections (3 lm)
were subjected to hematoxylin-eosin staining. For lipid staining,
frozen sections (10 lm) were prepared on glass slides (New Silane
II, Muto Pure Chemicals Col, Ltd., Tokyo, Japan), stained with oil red
O, washed with 60% 2-propanol, and counterstained with
hematoxylin.
4.7. Measurement of T-cho, TG, PL, and FFA in the liver
Liver tissues were homogenized with 2 vol water using a handy
homogenizer (Moji-mojikun; Nippon Genetics Co., Ltd., Tokyo,
Japan). Homogenates were added to a chloroform-methanol (2:1;
v/v) mixture, incubated for 60 min at 37 C, and centrifuged at
21,000g for 10 min at 4 C. The supernatant organic phase was
then collected, dried under nitrogen gas and resolubilized in 2-pro-
panol. TG, T-cho, PL, and FFA concentrations in total lipid extracts
were determined using commercial enzymatic kits (Wako Pure
Chemical Industries, Ltd., Osaka, Japan)
4.8. Thiobarbituric acid reactive substances (TBARS) assay
Lipid peroxidation was estimated by the amounts of TBARS in
the liver that were determined according to the method of Ohkawa
et al. [44]. The livers were ﬁrst homogenized in 10 vol ice-cold 0.1%
sodium dodecyl sulfate (SDS) using a handy homogenizer and a
sonicator. The homogenates were then centrifuged at 21,000g
for 15 min at 4 C and the supernatant was used for further assays.
Ten microliter of sample was mixed thoroughly with 175 lL stock
solution (0.023% (w/v) butylated hydroxytoluene, 0.926% (w/v)
SDS, 20% (v/v) acetic acid, pH 3.5), 150 lL 0.8% thiobarbituric acid,
and 70 lL distilled water. The mixture was kept on ice for 60 min
and then heated for 60 min in a boiling water bath. After cooling,
100 lL distilled water and 500 lL n-butyl alcohol-pyridine (15:1;
v/v) were added, and then the mixture was centrifuged at
21,000g for 5 min at 4 C. The organic phase supernatant ﬂuores-
cence was measured using a SPECTRAmax Gemini (Life Technolo-
gies Corp., Carlsbad, CA, USA) with an excitation and emission
wavelength set of 515 nm and 553 nm, respectively. The TBARS
levels are expressed as the equivalent amounts of malondialde-
hyde produced from 1,1,3,3-tetraethoxypropane.
4.9. Dihydroethidium (DHE) ﬂuorescence of liver tissue
DHE (Wako Pure Chemical Industries, Ltd.), an oxidative ﬂuo-
rescent dye, was used to detect superoxide anion radicals in frozen
liver tissue as described previously [45]. Frozen sections (20 lm)
were placed on glass slides and incubated with 5 lM DHE at
37 C for 30 min in a light-protected chamber. Images were
obtained using a ﬂuorescence microscope (IX70; Olympus Corp.,
Tokyo, Japan) with a wideband ﬁlter cube (U-MWIG; Olympus
Corp.) at excitation and emission wavelengths of 488 nm and
590 nm, respectively.
4.10. Western blot analysis
We used liver microsome fractions for Western blot analysis of
Apo B100, ApoB48, microsomal triglyceride transfer protein (MTP),
and glucose-regulated protein 78 kDa (Grp78) as described previ-
ously [17]. Brieﬂy, livers were homogenized using a Potter-type
Teﬂon homogenizer (model TH-M; Takashima, Tokyo, Japan) in
20 vol of ice cold 20 mM Tris-HCl, pH 7.4, 0.25 M sucrose, and aprotease inhibitor cocktail (cOmplete, EDTA-free; Roche Diagnos-
tics GmbH, Mannheim, Germany). Homogenates were centrifuged
at 8000g for 10 min at 4 C, and the supernatant was further cen-
trifuged at 100,000g for 60 min at 4 C. The pellets were sus-
pended in the same buffer. Equal amounts (55 lg for ApoB100
and ApoB48, and 10 lg for MTP and Grp78) of total protein were
subjected to 3–8% Tris-acetate gel electrophoresis for ApoB100
and ApoB48 or 7.5% SDS–PAGE for MTP and Grp78, and then elec-
troblotted onto polyvinylidene diﬂuoride membranes, which were
then blocked with Block Ace (DS Pharma Biomedical Co., Ltd.,
Osaka, Japan). The primary antibodies used were: anti-mouse
ApoB100 goat polyclonal antibody (1:500; H-15; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-human ApoB48 goat
polyclonal antibody (1:500; S-18; Santa Cruz Biotechnology),
anti-mouse MTP mouse monoclonal antibody (1:2500; 612022;
BD Biosciences, San Jose, CA, USA), and anti-human Grp78 mouse
monoclonal antibody (1:1000; 610978; BD Biosciences). Immuno-
reactive ApoB100, ApoB48 and Grp78 were visualized with
SuperSignalWest Femto Maximum Sensitivity Substrate (Thermo
Fisher Scientiﬁc Inc., Waltham, MA, USA) and a LAS-3000 imaging
system (GE Healthcare Japan, Tokyo, Japan). Immunoreactive MTP
was visualized with ECL (GE Healthcare Japan) and LAS-3000.
Western blot analysis of sterol regulatory element binding pro-
tein (SREBP)-1, SREBP2, and peroxisome proliferator-activated
receptor-a (PPARa) was performed with liver homogenates. Livers
were homogenized in ice cold homogenization buffer (50 mM Tris–
HCl (pH 7.6), 150 mM NaCl, 0.1% SDS, and a protease inhibitor
cocktail (cOmplete, EDTA-free) for 30 s using a high speed homog-
enizer (POLYTRON PT-MR 2100; Kinematica AG, Switzerland).
The homogenate was then centrifuged at 21,000g for 10 min at
4 C. The supernatants were boiled for 5 min with a lysis buffer
containing 0.125 M Tris–HCl (pH 6.8), 4% SDS, 20% glycerol, 10%
2-mercaptoethanol, and 0.2% bromophenol blue at a ratio of 1:1.
Total protein (6 lg) equivalents for each sample were separated
on a 5–20% polyacrylamide gel and transferred to a polyvinylidene
diﬂuoride membrane. The membranes were blocked in Block Ace
before incubation with the primary antibody, followed by incuba-
tion with a horseradish peroxidase-linked goat anti-mouse IgG
(1:5000; Bio-Rad Laboratories, Inc., Hercules, CA, USA) or a horse-
radish peroxidase-linked goat anti-rabbit IgG (1:5000; Bio-Rad
Laboratories, Inc.). The primary antibodies used were: anti-SREBP1
mouse monoclonal antibody (1:500, #MS-1207-P1ABX; Thermo
Fisher Scientiﬁc Inc.), anti-rat SREBP2 rabbit polyclonal antibody
(1:500; NB100-74543; Novus Biologicals, LLC, Littleton, CO, USA),
and anti-human PPARa rabbit polyclonal antibody (1:500; sc-
9000; Santa Cruz Biotechnology). After washing, the immunoreac-
tivity of SREBP1 and SREBP2 was detected using SuperSignalWest
Dura Extended Duration Substrate (Thermo Fisher Scientiﬁc Inc.)
and LAS-3000. Immunoreactive PPARa was visualized with Super-
SignalWest Femto Maximum Sensitivity Substrate and LAS-3000.
Chemiluminescence signals were quantiﬁed with Multi Gauge
ver.3.0 software (GE Healthcare Japan). The mean signals from ﬁve
Smp30Y/+Sod1+/+ mice were assigned a relative value of 1.0.
4.11. RNA isolation, ﬁrst-strand cDNA synthesis, and quantitative real-
time polymerase chain reaction (qPCR)
Liver tissue was homogenized in ice-cold ISOGEN reagent
(Nippon Gene Co., Ltd., Tokyo, Japan) with a handy homogenizer
before isolation of total RNA according to the manufacturer’s
instructions. RNA concentrations were determined and conﬁrmed
as free from protein contamination by measuring absorbance at
260 and 280 nm. Total RNA (2.5 lg) was reverse-transcribed using
SuperScript III Reverse Transcriptase (Life Technologies Corp.) for
ﬁrst-strand cDNA synthesis with Random Primer (hexa-deoxyribo-
nucleotide mixture; Takara Bio Inc., Shiga, Japan) according to the
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Super-Mix-UDG-with ROX (Life Technologies Corp.) following the
manufacturer’s protocol, qPCR reactions were performed. The
primers and probes used in the qPCR reactions were PrimeTime
qPCR Assays (Integrated DNA Technologies, Inc.); 50-CCT GCT TCT
CCG ATT ATA TTT GAA C-30, 50-CAC TGC AAC CTA TGA ACT CCT
AA-30, and 50-/56-FAM/ACT GCT GCA/ZEN/CTC CTT CTG CTT GA/
3IABkFQ/-30 for Apob (NM_009693); 50-GAC TCC TCC TTC TTC
TCA TCT TTC-30, 50-GTC ATC GCT CAG GGT GTT G-30, and 50-/56-
FAM/CTG TGG CTG/ZEN/TTT CTG CTG CCC/3IABkFQ/-30 for Rplp2,
ribosomal protein, large P2 (NM_026020). The reactions were per-
formed by using the StepOnePlus™ Real-Time PCR System (Life
Technologies Corp.). The product speciﬁcity generated for each
primer set was examined for gel electrophoresis. The relative
expression levels of Apob were normalized to Rplp2 using relative
standard method. Signals from Smp30Y/+Sod1+/+mice were assigned
a relative value of 1.0. Five animals from each group were exam-
ined, and qPCR was run in duplicate for each sample.
4.12. Determination of protein concentration
The protein concentration was determined by the bicinchoninic
acid protein assay using bovine serum albumin as a standard [46].
4.13. Statistical analysis
The values are expressed as means ± SEM. Statistical analyses
were performed with KaleidaGraph software (Synergy Software
Inc., Reading, PA, USA). The signiﬁcance of differences among the
groups was determined by analysis of variance and Turkey’s hon-
estly signiﬁcant difference test. Survival analysis was conducted
by Kaplan–Meier curves and log-rank tests using IBM SPSS Statis-
tics 20 (IBM Japan, Tokyo, Japan). Differences were considered sig-
niﬁcant at p < 0.05.
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